What is WEARABLE HEALTH SOLUTIONS's earnings per share (EPS)?

WEARABLE HEALTH SOLUTIONS (WHSI) reported diluted earnings per share of $0.00 for fiscal year 2023. This represents a 86.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

WEARABLE HEALTH SOLUTIONS (WHSI) Financials

WHSI

Trailing 12 months to December 31, 2023

Revenue $600K -29.6% YoY

Net Income -$956K YoY not available

EPS (Diluted) $0.00 +84.1% YoY

Free Cash Flow -$409K +82.7% YoY

Market Cap $183K as of Sep 21, 2026

Price / Sales 0.3x on $600K revenue, trailing 12 months to December 31, 2023

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to December 31, 2023

Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2024

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 21, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2024, ended Dec 31, 2023 Reported Feb 20, 2024 Currency USD FYE June

Newest figures come from the 10-Q for Q2 FY2024, filed Feb 20, 2024. Each column of the statement tables below links to the filing it was taken from.

WEARABLE HEALTH SOLUTIONS (WHSI) reported $600K in revenue over the twelve months to Dec 31, 2023, down 29.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI WHSI FY2023 2026-08-30

External financing offsets persistent internal cash deficits as shrinking sales and margin compression limit operating self-funding.

FY2023 revenue was $745K, below FY2018's $976K; the business therefore did not gain scale over that span. Gross margin also fell from 73.2% to 35.9%, and the intervening FY2021 sales rebound did not restore the earlier margin structure, pointing to cost or mix deterioration rather than fixed-cost absorption.

FY2023 liabilities were $3.8M against assets of $223K, a mismatch that leaves the balance sheet dependent on obligations rather than asset backing. Negative equity and a current ratio of 0.0x show that this is both a long-term solvency imbalance and a short-term working-capital constraint, not merely a timing issue.

Negative FCF narrowed from $3.2M in FY2022 to $1.3M in FY2023, yet remained a use of cash rather than a source. Positive financing cash flow supplied the offset in both years, indicating that reported cash needs were being met through external funding; the latest liquidity comparison equaled 1.3 months of reported operating outflow.

Financial Health Signals

Financial health score not available

WEARABLE HEALTH SOLUTIONS does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-312.36

WEARABLE HEALTH SOLUTIONS scores -312.36, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($183K) relative to total liabilities ($3.8M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/7

WEARABLE HEALTH SOLUTIONS passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 3 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

WEARABLE HEALTH SOLUTIONS reported a net loss of $2.4M while operations used $1.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

WEARABLE HEALTH SOLUTIONS reported an operating loss of $2.3M against $11K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$127K

YoY-35.7%

QoQ-10.6%

5Y CAGR-10.8%

WEARABLE HEALTH SOLUTIONS generated $127K in revenue in Q2 2024. This represents a decrease of 35.7% from the same quarter a year earlier. Against the prior quarter it is down 10.6%.

EBITDA

-$68K

YoY+86.7%

QoQ+79.4%

WEARABLE HEALTH SOLUTIONS's EBITDA was -$68K in Q2 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 86.7% from the same quarter a year earlier. Against the prior quarter it is up 79.4%.

Net Income

$125K

YoY+123.2%

QoQ+562.5%

WEARABLE HEALTH SOLUTIONS reported $125K in net income in Q2 2024. This represents an increase of 123.2% from the same quarter a year earlier. Against the prior quarter it is up 562.5%.

EPS (Diluted)

$0.00

WEARABLE HEALTH SOLUTIONS earned $0.00 per diluted share (EPS) in Q2 2024.

Cash & Balance Sheet

Free Cash Flow

-$10K

YoY+97.9%

QoQ+94.1%

WEARABLE HEALTH SOLUTIONS recorded an outflow of $10K in free cash flow in Q2 2024, representing a cash shortfall after capex. This represents an increase of 97.9% from the same quarter a year earlier. Against the prior quarter it is up 94.1%.

Cash & Debt

$410

YoY-99.1%

QoQ-96.2%

WEARABLE HEALTH SOLUTIONS held $410 in cash as of Q2 2024; long-term debt is not reported for that period.

Shares Outstanding

1.83B

YoY+19.1%

QoQ+1.2%

WEARABLE HEALTH SOLUTIONS had 1.83B shares outstanding in Q2 2024. This represents an increase of 19.1% from the same quarter a year earlier. Against the prior quarter it is up 1.2%.

Dividends Per Share

Not reported for Q2 2024.

Margins & Returns

Gross Margin

34.6%

YoY-15.2pp

QoQ-30.2pp

5Y change-27.0pp

WEARABLE HEALTH SOLUTIONS's gross margin was 34.6% in Q2 2024, indicating the percentage of revenue retained after direct costs. This is down 15.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 30.2 percentage points.

Operating Margin

-56.3%

WEARABLE HEALTH SOLUTIONS's operating margin was -56.3% in Q2 2024, reflecting core business profitability. No change is given against Q2 2023: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

98.4%

QoQ+85.1pp

WEARABLE HEALTH SOLUTIONS's net profit margin was 98.4% in Q2 2024, showing the share of revenue converted to profit. Against the prior quarter it is up 85.1 percentage points. No change is given against Q2 2023: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for Q2 2024.

Capital Allocation

R&D Spending

QoQ-100.0%

WEARABLE HEALTH SOLUTIONS reported no research and development spending in Q2 2024. Against the prior quarter it is down 100.0%.

Capital Expenditures

WEARABLE HEALTH SOLUTIONS reported no capital expenditure in Q2 2024.

Share Buybacks

Not reported for Q2 2024.

WHSI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WHSI quarterly income statement

Metric	TTM	FY2310-K	FY2210-K	FY2110-K	FY1910-K	FY1810-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$600K	$745K-28.8%	$1.0M-25.0%	$1.4M	$770K-21.1%	$976K	$1.3M+12.9%	$1.1M-0.6%	$1.2M+101.4%	$573K+7.5%	$533K+17.7%	$453K
Cost of Revenue	$391K	$477K-16.0%	$568K-34.6%	$869K	$398K+52.3%	$261K	$396K+7.1%	$370K+13.9%	$325K-26.5%	$442K+4.3%	$424K+151.3%	$169K
Gross Profit	$209K	$268K-43.9%	$477K-9.0%	$525K	$372K-47.9%	$715K	$900K+15.7%	$778K-6.2%	$829K+533.3%	$131K+20.0%	$109K-61.6%	$284K
R&D Expenses	$63K	$50K-87.3%	$391K	$0	$0	$0	$32K	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$295K	$348K-14.9%	$409K-42.8%	$716K	$781K-15.5%	$924K	$1.4M+39.4%	$984K-42.0%	$1.7M+169.9%	$628K-5.3%	$664K-49.8%	$1.3M
Operating Income	-$1.4M	-$2.3M	N/A	-$3.2M	-$435K-77.9%	-$244K	N/A	N/A	N/A	N/A	-$615K+54.7%	-$1.4M
EBITDA	N/A	-$2.3M	N/A	-$3.2M	-$427K-88.6%	-$226K	N/A	N/A	N/A	N/A	-$531K+47.9%	-$1.0M
Interest Expense	N/A	$11K-12.0%	$12K-94.5%	$221K	$281K+716.9%	$34K	$157K+33.6%	$117K-38.0%	$189K-66.8%	$569K-41.0%	$966K-7.8%	$1.0M
Income Tax	$0	$0	$0	$0	$0	$0	N/A	N/A	N/A	N/A	$0	$0
Net Income	-$956K	-$2.4M	N/A	-$3.3M	-$715K-156.7%	-$279K	-$780K-194.4%	$827K+267.4%	$225K-92.9%	$3.2M	N/A	-$408K
EPS (Basic)	N/A	$0.00+86.7%	-$0.01-90.5%	-$0.01	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	$0.00	$0.00+86.7%	-$0.01	-$0.01	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	1.54B+41.4%	1.09B	527M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Revenue	$127K-35.7%	$142K-34.2%	$137K-39.3%	$194K-9.0%	$198K-35.0%	$216K-28.5%	$226K-37.1%	$213K-24.8%
Cost of Revenue	$83K-16.2%	$50K-58.2%	$123K+11.3%	$135K+21.3%	$99K-30.5%	$120K-41.0%	$110K-49.6%	$111K+48.2%
Gross Profit	$44K-55.4%	$92K-4.3%	$14K-87.8%	$59K-42.4%	$99K-38.9%	$96K-2.9%	$115K-17.5%	$102K-51.2%
R&D Expenses	$0	$15K+597.2%	$48K+21.2%	$0-100.0%	$0-100.0%	$2K-98.5%	-$39K	$210K
SG&A Expenses	$29K-64.1%	$80K-2.5%	$102K-40.1%	$84K-6.2%	$80K+20.5%	$82K-1.0%	$171K-72.6%	$89K+258.7%
Operating Income	-$72K+86.2%	-$336K+55.8%	-$535K	-$480K	-$519K+14.4%	-$760K+81.4%	N/A	N/A
EBITDA	-$68K+86.7%	-$332K+56.1%	-$532K	-$476K	-$516K+14.6%	-$757K+81.5%	N/A	N/A
Interest Expense	N/A	$3K0.0%	$591+101.1%	$3K-60.5%	$3K-85.8%	$3K-90.3%	-$56K-134.9%	$8K-69.7%
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	$125K+123.2%	$19K+102.5%	-$578K	-$522K	-$540K-46.3%	-$749K+82.8%	N/A	N/A
EPS (Basic)	$0.00	$0.00	$0.00-113.8%	$0.00+95.9%	$0.00+100.0%	$0.00+100.0%	$0.00	-$0.01
EPS (Diluted)	$0.00	$0.00	$0.00-113.8%	$0.00+95.9%	$0.00+100.0%	$0.00+100.0%	$0.00	-$0.01
Diluted Shares (Avg)	2.33B+52.4%	2.17B+43.0%	N/A	1.54B+52.3%	1.53B+47.9%	1.52B+676.8%	N/A	1.01B

WHSI Balance Sheet

WHSI quarterly balance sheet

Metric	FY2310-K	FY2210-K	FY2110-K	FY1910-K	FY1810-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$223K-34.2%	$339K-62.7%	$908K	$119K-48.5%	$230K	$571K+107.8%	$275K-76.5%	$1.2M-7.3%	$1.3M-10.1%	$1.4M+1.6%	$1.4M
Current Assets	$152K-48.8%	$297K-67.2%	$908K	$112K-48.1%	$216K	$521K+89.9%	$275K+307.1%	$67K-11.5%	$76K-42.8%	$133K+381.3%	$28K
Cash & Equivalents	$136K+93.1%	$71K-91.7%	$847K	$4K-15.3%	$5K	$106K+7870.9%	$1K-82.6%	$8K+31.0%	$6K-71.5%	$21K+93431.8%	$22
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$9K+21.1%	$7K	$0	$5K-94.2%	$91K	$8K-88.9%	$68K+197.7%	$23K-12.6%	$26K-49.8%	$52K+131.7%	$22K
Accounts Receivable	$379	$0-100.0%	$26K	$12K-84.1%	$77K	$78K-21.1%	$99K+167.0%	$37K+218.4%	$12K+1324.2%	$815-84.4%	$5K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$3.8M+56.3%	$2.4M-42.9%	$4.3M	$2.3M+32.8%	$1.7M	$1.7M+56.0%	$1.1M-66.2%	$3.2M-51.4%	$6.6M-43.4%	$11.6M+242.2%	$3.4M
Current Liabilities	$3.8M+55.5%	$2.4M-42.9%	$4.3M	$1.9M+10.1%	$1.7M	$1.3M+85.9%	$695K-78.3%	$3.2M-1.5%	$3.3M-63.7%	$9.0M+1190.0%	$694K
Non-Current Liabilities	$18K	$0	$0	$398K	$0	$398K+2.4%	$388K-84.5%	$2.5M-25.2%	$3.3M+24.0%	$2.7M-0.5%	$2.7M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$225K	N/A	N/A
Total Equity	-$3.6M-71.0%	-$2.1M+37.6%	-$3.4M	-$2.2M-45.1%	-$1.5M	-$1.1M-38.4%	-$809K+60.3%	-$2.0M+61.9%	-$5.3M+47.9%	-$10.2M-406.1%	-$2.0M
Retained Earnings	-$41.8M-6.1%	-$39.4M-49.5%	-$26.4M	-$18.9M-3.9%	-$18.2M	-$14.2M-5.8%	-$13.4M+5.8%	-$14.2M+1.6%	-$14.5M+18.1%	-$17.7M-151.4%	-$7.0M

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Total Assets	$90K-57.1%	$125K-70.6%	$223K-34.2%	$130K-79.5%	$209K-87.6%	$426K-77.1%	$339K-62.7%	$632K
Current Assets	$32K-74.2%	$61K-81.8%	$152K-48.8%	$52K-91.1%	$125K-92.4%	$336K-81.5%	$297K-67.2%	$588K
Cash & Equivalents	$410-99.1%	$11K-95.8%	$136K+93.1%	$16K-97.1%	$45K-97.2%	$256K-85.4%	$71K-91.7%	$570K+4824.2%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$5K-92.0%	$9K-79.2%	$9K+21.1%	$33K	$64K	$41K	$7K	$0
Accounts Receivable	$27K+189.9%	$14K-17.0%	$379	$812	$9K-27.8%	$17K	$0-100.0%	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$3.2M+18.5%	$3.6M+45.0%	$3.8M+56.3%	$3.0M+21.8%	$2.7M+1.7%	$2.5M-37.8%	$2.4M-42.9%	$2.5M
Current Liabilities	$3.2M+24.1%	$3.6M+46.2%	$3.8M+55.5%	$3.0M+20.9%	$2.6M-3.3%	$2.4M-38.5%	$2.4M-42.9%	$2.5M
Non-Current Liabilities	$11K-91.7%	$15K-49.5%	$18K	$22K	$130K	$29K	$0	$0
Total Equity	-$3.1M-24.9%	-$3.4M-69.2%	-$3.6M-71.0%	-$2.9M-56.4%	-$2.5M-158.9%	-$2.0M+2.7%	-$2.1M+37.6%	-$1.9M
Retained Earnings	-$41.7M-2.3%	-$41.8M-4.0%	-$41.8M-6.1%	-$41.2M-7.2%	-$40.7M-30.9%	-$40.2M-30.7%	-$39.4M-49.5%	-$38.5M

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

WHSI Cash Flow Statement

WHSI quarterly cash flow statement

Metric	TTM	FY2310-K	FY2210-K	FY2110-K	FY1910-K	FY1810-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$409K	-$1.3M+58.8%	-$3.1M-164.8%	-$1.2M	-$132K-26.5%	-$105K	N/A	N/A	N/A	-$497K+28.1%	-$691K-148.2%	-$278K
Depreciation & Amortization	N/A	$12K+48.6%	$8K	$0	$7K-58.1%	$18K	$4K-94.4%	$76K+1341.0%	$5K-93.7%	$84K0.0%	$84K-75.2%	$337K
Stock-Based Compensation	N/A	$294K-97.1%	$10.0M+452.9%	$1.8M	N/A	N/A	N/A	$0	$0-100.0%	$28K-71.3%	$98K-79.9%	$488K
Capital Expenditures	$0	$9K-81.1%	$50K	$0	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	-$409K	-$1.3M+59.2%	-$3.2M-169.1%	-$1.2M	-$132K-26.5%	-$105K	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	-$9K+81.1%	-$50K	$0	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$364K	$1.4M-43.1%	$2.4M+17.8%	$2.0M	$132K+67.7%	$79K	$933K+90.3%	$490K+1681.9%	$28K-94.3%	$482K-32.2%	$712K+155.6%	$278K

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Operating Cash Flow	-$10K+97.9%	-$175K+68.9%	-$117K+73.1%	-$106K+87.7%	-$495K+38.6%	-$561K+43.9%	-$436K+40.3%	-$864K-2170.7%
Depreciation & Amortization	$3K0.0%	$3K+29.2%	$3K+31.5%	$3K+31.4%	$3K+31.5%	$3K+199.6%	$3K	$3K
Stock-Based Compensation	N/A	$2K	N/A	N/A	N/A	$0-100.0%	N/A	N/A
Capital Expenditures	$0	$0-100.0%	$0	$0	$0	$9K-81.1%	$0	$0
Free Cash Flow	-$10K+97.9%	-$175K+69.4%	-$117K+73.1%	-$106K+87.7%	-$495K+38.6%	-$571K+45.7%	-$436K+40.3%	-$864K-2170.7%
Investing Cash Flow	$0	$0+100.0%	$0	$0	$0	-$9K+81.1%	$0-100.0%	$0
Financing Cash Flow	$0-100.0%	$49K-93.5%	$237K+474.1%	$77K+146.5%	$284K-56.5%	$756K-61.4%	-$63K-104.1%	-$166K-449.1%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

WHSI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WHSI quarterly financial ratios

Metric	FY2310-K	FY2210-K	FY2110-K	FY1910-K	FY1810-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	35.9%-9.7pp	45.6%+8.0pp	37.6%	48.3%-24.9pp	73.2%	69.4%+1.7pp	67.8%-4.1pp	71.9%+49.0pp	22.9%+2.4pp	20.5%-42.3pp	62.8%
Operating Margin	-307.9%	N/A	-226.8%	-56.4%-31.4pp	-25.0%	N/A	N/A	N/A	N/A	-115.4%	-299.7%
Net Margin	-320.6%	N/A	-237.6%	-92.9%-64.3pp	-28.6%	-60.2%-132.3pp	72.1%+52.6pp	19.5%	556.8%	N/A	-90.0%
Return on Assets	-1070.2%	N/A	-365.0%	-603.8%-482.6pp	-121.2%	-136.7%-437.7pp	301.0%+281.7pp	19.3%-233.9pp	253.2%	N/A	-29.6%
Current Ratio	0.04-0.1x	0.12-0.1x	0.21	0.06-0.1x	0.12	0.400.0x	0.40+0.4x	0.020.0x	0.020.0x	0.010.0x	0.04
Asset Turnover	3.34+0.3x	3.08+1.5x	1.54	6.50+2.3x	4.24	2.27-1.9x	4.18+3.2x	0.99+0.5x	0.45+0.1x	0.38+0.1x	0.33
FCF Margin	-173.0%	-301.9%	-84.2%	-17.2%-6.5pp	-10.7%	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Gross Margin	34.6%-15.2pp	64.8%+20.2pp	10.3%-40.8pp	30.2%-17.5pp	49.8%-3.2pp	44.6%+11.8pp	51.1%+12.1pp	47.7%-25.8pp
Operating Margin	-56.3%	-235.8%	-391.0%	-247.6%	-262.3%	-351.1%	N/A	N/A
Net Margin	98.4%	13.3%	-422.2%	-269.5%	-272.6%	-345.9%	N/A	N/A
Return on Assets	139.8%+398.3pp	15.1%+190.8pp	-258.9%	-401.9%	-258.5%-236.6pp	-175.7%+58.0pp	N/A	N/A
Current Ratio	0.010.0x	0.02-0.1x	0.04-0.1x	0.02-0.2x	0.05-0.6x	0.14-0.3x	0.12-0.1x	0.24
Asset Turnover	1.42+0.5x	1.14+0.6x	0.61-0.1x	1.49+1.2x	0.95+0.8x	0.51+0.3x	0.67+0.3x	0.34
FCF Margin	-8.1%	-122.7%	-85.9%	-54.8%	-249.8%	-263.6%	-193.3%	-405.8%

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$3.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.04), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
WEARABLE HEALTH SOLUTIONS WHSI	FY2023	$745K	-$2.4M	N/A	$183K	—
INNERSCOPE HEARNG TECH INND	FY2020	$166K	-$5.0M	N/A	$39K	—
UNITED HEALTH PRODUTS INC UEEC	FY2025	$0	N/A	N/A	$8.4M	—

Where WEARABLE HEALTH SOLUTIONS Ranks

Frequently Asked Questions

What is WEARABLE HEALTH SOLUTIONS's annual revenue?

WEARABLE HEALTH SOLUTIONS (WHSI) reported $745K in total revenue for fiscal year 2023. This represents a -28.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is WEARABLE HEALTH SOLUTIONS's revenue growing?

WEARABLE HEALTH SOLUTIONS (WHSI) revenue declined by 28.8% year-over-year, from $1.0M to $745K in fiscal year 2023.

Is WEARABLE HEALTH SOLUTIONS profitable?

No, WEARABLE HEALTH SOLUTIONS (WHSI) reported a net income of -$2.4M in fiscal year 2023.

What is WEARABLE HEALTH SOLUTIONS's EBITDA?

WEARABLE HEALTH SOLUTIONS (WHSI) had EBITDA of -$2.3M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.

What is WEARABLE HEALTH SOLUTIONS's gross margin?

WEARABLE HEALTH SOLUTIONS (WHSI) had a gross margin of 35.9% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.

What is WEARABLE HEALTH SOLUTIONS's free cash flow?

WEARABLE HEALTH SOLUTIONS (WHSI) recorded an outflow of $1.3M in free cash flow during fiscal year 2023. This represents a 59.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is WEARABLE HEALTH SOLUTIONS's operating cash flow?

WEARABLE HEALTH SOLUTIONS (WHSI) recorded an outflow of $1.3M in operating cash flow during fiscal year 2023, representing cash used by core business activities.

What are WEARABLE HEALTH SOLUTIONS's total assets?

WEARABLE HEALTH SOLUTIONS (WHSI) had $223K in total assets as of fiscal year 2023, including both current and long-term assets.

What are WEARABLE HEALTH SOLUTIONS's capital expenditures?

WEARABLE HEALTH SOLUTIONS (WHSI) invested $9K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.

How much does WEARABLE HEALTH SOLUTIONS spend on research and development?

WEARABLE HEALTH SOLUTIONS (WHSI) invested $50K in research and development during fiscal year 2023.

How many shares does WEARABLE HEALTH SOLUTIONS have outstanding?

WEARABLE HEALTH SOLUTIONS (WHSI) had 1.80B shares outstanding as of fiscal year 2023.

What is WEARABLE HEALTH SOLUTIONS's current ratio?

WEARABLE HEALTH SOLUTIONS (WHSI) had a current ratio of 0.04 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.

What is WEARABLE HEALTH SOLUTIONS's return on assets (ROA)?

WEARABLE HEALTH SOLUTIONS (WHSI) had a return on assets of -1070.2% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

What is WEARABLE HEALTH SOLUTIONS's P/E ratio?

WEARABLE HEALTH SOLUTIONS (WHSI) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to December 31, 2023). The market capitalization is $183K as of Sep 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is WEARABLE HEALTH SOLUTIONS's price-to-sales ratio?

WEARABLE HEALTH SOLUTIONS (WHSI) trades at 0.3x sales, its market capitalization divided by revenue of $600K revenue, trailing 12 months to December 31, 2023. The market capitalization is $183K as of Sep 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does WEARABLE HEALTH SOLUTIONS's liquidity compare with its operating cash outflow?

At the end of fiscal year 2023, WEARABLE HEALTH SOLUTIONS (WHSI) held $136K in cash, cash equivalents and investments, and reported an operating cash outflow of $1.3M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Why is WEARABLE HEALTH SOLUTIONS's debt-to-equity ratio negative or not reported?

WEARABLE HEALTH SOLUTIONS (WHSI) has negative shareholder equity of -$3.6M as of fiscal year 2023, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is WEARABLE HEALTH SOLUTIONS's Altman Z-Score?

WEARABLE HEALTH SOLUTIONS (WHSI) has an Altman Z-Score of -312.36, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is WEARABLE HEALTH SOLUTIONS's Piotroski F-Score?

WEARABLE HEALTH SOLUTIONS (WHSI) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are WEARABLE HEALTH SOLUTIONS's earnings high quality?

WEARABLE HEALTH SOLUTIONS (WHSI) reported a net loss of $2.4M while operations used $1.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can WEARABLE HEALTH SOLUTIONS cover its interest payments?

WEARABLE HEALTH SOLUTIONS (WHSI) reported an operating loss of $2.3M against $11K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.